Industry-Sponsored Symposium - Eosinophilic Esophagitis: Novel Therapeutic Developments and Impact on Treatment Paradigms

Evan S. Dellon, MD, MPH, FACG (Activity Chair); Claire A. Beveridge, MD; Mirna Chehade, MD, MPH; Ikuo Hirano, MD, FACG

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi

In this educational program, expert clinicians will review the pathogenesis and best practices for accurate diagnosis of eosinophilic esophagitis (EoE). They will also explore current treatment guidelines and the clinical data supporting the use of recently approved and emerging therapies for EoE. Interactive case discussions are included to challenge the audience’s ability to apply the learnings from the didactic presentations.

Open to all ACG 2022 attendees, industry-sponsored symposia provide additional educational opportunities. These programs are independent of the ACG 2022 Annual Scientific Meeting and Postgraduate Course programs. ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.